Based on the Airsculpt Technologies Inc stock forecast from 2 analysts, the average analyst target price for Airsculpt Technologies Inc is USD 4.50 over the next 12 months. Airsculpt Technologies Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Airsculpt Technologies Inc is Bearish, which is based on 3 positive signals and 8 negative signals. At the last closing, Airsculpt Technologies Inc’s stock price was USD 2.11. Airsculpt Technologies Inc’s stock price has changed by +24.12% over the past week, -7.86% over the past month and -62.19% over the last year.
No recent analyst target price found for Airsculpt Technologies Inc
No recent average analyst rating found for Airsculpt Technologies Inc
Company Overview Airsculpt Technologies Inc
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida. Read Less
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body cont...Read More
Frequently Asked Questions About Airsculpt Technologies Inc (AIRS) Stock
Based on ratings from 2 analysts Airsculpt Technologies Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Bearish. The stock has buy, sell and 3 hold ratings.
Unfortunately we do not have enough data on AIRS's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for AIRS is USD 4.50 over the next 12 months. The maximum analyst target price is USD 6 while the minimum anlayst target price is USD 2.5.
AIRS stock's Price/Earning ratio is 197.00.
Our analysis grades AIRS stock's Price / Earning ratio at F. This means that AIRS stock's Price/Earning ratio is above 88% of the stocks in the Medical Care Facilities sector in the NSD exchange.
Based on this AIRS may be a overvalued for its sector.
The last closing price of AIRS's stock was USD 2.11.
The most recent market capitalization for AIRS is USD 0.12B.
Based on targets from 2 analysts, the average taret price for AIRS is projected at USD 4.50 over the next 12 months.
This means that AIRS's stock price may go up by +113.27% over the next 12 months.
We can't find any ETFs which contains Airsculpt Technologies Inc's stock.
As per our most recent records Airsculpt Technologies Inc has 389 Employees.
Airsculpt Technologies Inc's registered address is 1111 Lincoln Road, Miami Beach, FL, United States, 33139.
You can get more information about it from Airsculpt Technologies Inc's website at https://airsculpt.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Airsculpt Technologies Inc (AIRS) Stock
Based on ratings from 2 analysts Airsculpt Technologies Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Bearish. The stock has buy, sell and 3 hold ratings.
Unfortunately we do not have enough data on AIRS's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for AIRS is USD 4.50 over the next 12 months. The maximum analyst target price is USD 6 while the minimum anlayst target price is USD 2.5.
AIRS stock's Price/Earning ratio is 197.00.
Our analysis grades AIRS stock's Price / Earning ratio at F. This means that AIRS stock's Price/Earning ratio is above 88% of the stocks in the Medical Care Facilities sector in the NSD exchange.
Based on this AIRS may be a overvalued for its sector.
The last closing price of AIRS's stock was USD 2.11.
The most recent market capitalization for AIRS is USD 0.12B.
Based on targets from 2 analysts, the average taret price for AIRS is projected at USD 4.50 over the next 12 months.
This means that AIRS's stock price may go up by +113.27% over the next 12 months.
We can't find any ETFs which contains Airsculpt Technologies Inc's stock.
As per our most recent records Airsculpt Technologies Inc has 389 Employees.
Airsculpt Technologies Inc's registered address is 1111 Lincoln Road, Miami Beach, FL, United States, 33139.
You can get more information about it from Airsculpt Technologies Inc's website at https://airsculpt.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AIRS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
